CONTENTS:
- The price of a cigarette: 20 minutes of life? [Editorial]. Jackson S.E., Jarvis M.J., West R., p. 810-812.
- Efficacy of cannabidiol alone or in combination with Δ-9-tetrahydrocannabinol for the management of substance use disorders: An umbrella review of the evidence. Redonnet B., Eren F., Avenin G., Melchior M., Mary-Krause M., p. 813-834.
- Extended-release pharmacotherapies for substance use disorders in incarcerated populations: A systematic review. Woods A., Foley C., Conigrave K.M., Asare-Doku W., Shakeshaft A., Settumba-Stolk S., et al., p. 835-859.
- The effect of proportional pricing on alcohol purchasing in two online experiments. Kersbergen I., Copeland A., Pryce R., Meier P., Field M., p. 860-870.
- Commentary on Kersbergen et al.: Same Price, same choices? Proportional pricing and the heaviest drinkers. Burton R., Sheron N., p. 871-872.
- Quantification of racial and ethnic disparities in alcohol-related problems in light of different methodological approaches. Ye Y., Lui C.K., Martinez P., Greenfield T.K., Kerr W.C., p. 873-883.
- Association between change in alcohol use reported during routine healthcare screening and change in subsequent hospitalization: A retrospective cohort study. Jack H.E., Berger D.B., Bobb J.F., Oliver M.M., Bradley K.A., Hallgren K.A., p. 884-894.
- Daily associations between sleep and alcohol use among veterans: Acute and cumulative effects. Miller M.B., Wycoff A.M., Tracy E.L., Moskal K.R., Borsari B., Bartholow B.D., et al., p. 895-904.
- The effectiveness of a drink-counting and a breathalyser-coupled smartphone application for reduced heavy drinking among alcohol-dependent adults in Sweden: A randomised controlled trial. Östh J., Lundin A., Wennberg P., Andréasson S., Danielsson A.K., p. 905-918.
- Commentary on Östh et al.: Sensor-based approaches to inform alcohol interventions - beyond BAC. Suffoletto B., p. 919-921.
- intEgrating Smoking Cessation treatment As part of usual Psychological care for dEpression and anxiety (ESCAPE): A randomised and controlled, multi-centre, acceptability and feasibility trial with nested qualitative methods. Taylor G.M.J., Sawyer K., Jacobsen P., Freeman T.P., Blackwell A., Daryan S., et al., p. 922-936.
- Outcomes of an organisational change program aimed at increasing smoking cessation support within Australian community managed mental health organisations: A cluster randomised controlled trial. Twyman L., Walsberger S., Baker A.L., Ahmadi S., Oldmeadow C., Weber M., et al., p. 937-950.
- Nationwide trends in diagnosed sedative, hypnotic or anxiolytic use disorders in adolescents and young adults enrolled in Medicaid: 2001-2019. Bushnell G., Lloyd K., Olfson M., Gerhard T., Keyes K., Cerda M., et al., p. 951-961.
- Prevalence of cannabis consumption methods among people with medically recommended and nonmedical cannabis use in the United States. Han B., Jones C.M., Volkow N.D., Einstein E.B., Weiss S.R.B., Blanco C., et al., p. 962-974.
- Visual function and vehicle driving performance under the effects of cannabidiol: A randomized cross-over experiment. Ortiz-Peregrina S., Martino F., Casares-Lopez M., Granados-Delgado P., Anera R.G., Castro Torres J.J., p. 975-983.
- Impulsivity behaviors and white matter mediate the relationship between genetic risk for cannabis use disorder and early cannabis use in adolescents. Cupertino R.B., Medland S.E., Ottino-Gonzalez J., Cao Z., Juliano A., Pancholi D., et al., p. 984-996.
- A cross-sectional study of differences in medication for opioid use disorder receipt among pregnant people enrolled in Medicaid in Oregon, United States. Cioffi C.C., Acevedo A.M., Cohen D.J., Kaufman M.R., Parker K., Terplan M., et al., p. 997-1006.
- Is methamphetamine blood concentration in emergency department patients associated with the clinical picture? McCutcheon D., Soderstrom J., Raghavan M., Oosthuizen F., Douglas B., Burrows S., et al., p. 1007-1015.
- Effects of personalized and normative feedback via the Positive Play Quiz on responsible gambling intention, self-efficacy and behavior: A randomized controlled trial. Tabri N., Wood R.T.A., Wohl M.J.A., p. 1016-1027.
- The effect of a brief intervention video on gambling advertising resistance: Results of a randomized, on-line experimental study. Torrance J., Russell A.M.T., Heath C., Newall P., p. 1028-1039.
- Mortality risk among individuals who smoke opioids compared with those who inject: A propensity score-matched cohort analysis of United States national treatment data. Karandinos G., Unick J., Ciccarone D., p. 1040-1045.
- Rare but relevant: Nitrous oxide and peripheral neurotoxicity, what do we know? Brunt T.M., van den Brink W., van Amsterdam J., p. 1046-1050.
- How did investigations into spontaneous human combustion influence alcohol medicine? An examination of the medical and literary discussions that brought the two together. Smith I., Lock P., p. 1051-1057.
- Re: The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: A real-world data analysis. Wang Y., Winterstein A.G., p. 1060-1061.
- Response to Wang and Winterstein: Robustness of GIP/GLP-1 RA findings in substance use disorders. Qeadan F., McCunn A., Tingey B., p. 1062-1063.